CJC-1295

Usually resolves within hours to days. Minimize by rotating injection sites, allowing solution to reach room temperature, and using proper injection technique. Apply ice if swelling persists.

Transient redness and warmth, typically occurring within 15-30 minutes of injection. Usually subsides within 1-2 hours. More common with higher doses or rapid injection.

May occur in the hours following injection. Usually mild and self-resolving. Ensure adequate hydration and consider timing injections before bed to sleep through symptom onset.

Transient and typically mild. Sit or lie down if experienced. Ensure you are well-hydrated and have eaten adequately before injection.

GH stimulation can increase appetite, particularly in the hours following injection. This is a physiological response to elevated GH and IGF-1 levels.

GH can increase sodium retention and fluid accumulation, particularly in the hands, feet, or face. Usually mild and reversible upon dose reduction or discontinuation. Ensure adequate hydration and monitor sodium intake.

May occur as GH levels increase, particularly in the first 1-2 weeks of use. Usually resolves as the body adapts. Ensure adequate stretching and consider dose reduction if severe.

Chronic GH elevation can increase risk of carpal tunnel syndrome due to tissue growth and fluid retention. If numbness or tingling in hands develops, discontinue and seek medical evaluation.

GH is diabetogenic and can impair insulin sensitivity or raise fasting glucose. Monitor blood glucose, particularly if you have a family history of diabetes or metabolic syndrome. Discontinue if fasting glucose exceeds 126 mg/dL or HbA1c rises significantly.

Chronic GH elevation can increase blood pressure through sodium retention and increased cardiac output. Monitor blood pressure regularly. Discontinue if systolic BP consistently exceeds 160 mmHg or diastolic exceeds 100 mmHg.

GH can increase aromatase activity and estrogen levels in some individuals. More likely if combined with anabolic steroids. Monitor for breast tenderness or enlargement; consider dose reduction or discontinuation if develops.

Prolonged excessive GH elevation can cause coarsening of facial features, hand/foot enlargement, and jaw growth. This is a sign of GH excess and requires immediate dose reduction or discontinuation and medical evaluation.

CJC-1295 stimulates pituitary somatotrophs; individuals with undiagnosed pituitary tumors or adenomas may experience tumor growth. Baseline pituitary MRI is recommended before starting therapy, particularly if there is a personal or family history of pituitary disease.

GH can suppress TSH and thyroid function in some individuals. Monitor TSH and free T4 at baseline and every 3-6 months. If TSH rises above 4.0 mIU/L or free T4 drops below normal range, consider thyroid supplementation or dose reduction.

Hypersensitivity to CJC-1295 or bacteriostatic water components is rare but possible. If rash, hives, difficulty breathing, or throat swelling occurs, discontinue immediately and seek emergency medical care.